TLDR Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.
The article suggests that Finasteride, a type II 5α-reductase inhibitor, could improve the viability of Mesenchymal stem cells (MSCs) used in cell therapy for myocardial infarction. Finasteride could enhance post-transplanted MSC viability by activating the PI3K/Akt pathway and increasing the facilitation of differentiation of MSCs to cardiomyocyte by reducing DHT levels. The article proposes that pretreating MSCs with Finasteride before administering for myocardial infarction could be a possible means of elevating cell survival.
9 citations,
January 2009 in “PubMed” Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.
October 2023 in “Biomaterials” Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.
January 2024 in “Journal of Biosciences and Medicines” Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.
October 2021 in “Cosmoderma” Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.
22 citations,
October 2018 in “Aesthetic Plastic Surgery” Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.
November 2024 in “Journal of Translational Internal Medicine” Exosomes from stem cells help hair regrowth by activating a specific signaling pathway.